Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Psychopharmacol. 2013 Aug 7;27(10):894–902. doi: 10.1177/0269881113499204

Table 2.

Unweighted means from the mixed model for binding potential (BPP) pre- and post-treatment. Means are given for the mixed model both with and without using Montgomery-Asberg Depression Rating Scale (MADRS) as a covariate.

BPP Without MADRS covariate
With MADRS covariate
Pre-treatment Post-treatment Pre-treatment Post-treatment
LACC 4.213 4.922 3.893 5.415a
RACC 4.333 4.948 4.012 5.339a
LAI 4.653 5.391 4.332 5.752a
RAI 4.684 5.483 4.363 5.869a
LMTC 7.456 9.121a 7.136 9.455a
RMTC 7.286 8.219b 6.966 8.678a
LPCC 3.918 4.485 3.597 4.944a
RPCC 3.710 4.312 3.390 4.823a
LPOC 3.624 4.424 3.304 4.756a
RPOC 3.702 4.333 3.382 4.730a
Raphe 3.314 3.257 2.993 3.580
a

Indicates that post-treatment value is significantly different from pre-treatment value at p<0.05 after both FDR and Bonferroni correction for multiple comparisons.

b

Indicates that post-treatment value trended towards a significant difference from pre-treatment value at 0.05<p<0.1 after FDR correction for multiple comparisons.

LACC and RACC: left and right anterior cingulate cortex; LAI and RAI: left and right anterior insula; LMTC and RMTC: left and right mesiotemporal cortex; LPCC and RPCC: left and right posterior cingulate cortex, LPOC and RPOC: left and right parieto-occipital cortex. MADRS: Montgomery-Asberg Depression Rating Scale.